相关实验视频
Updated: Sep 14, 2025

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
1.1K
特兰胺酸对患有创伤性出血的儿童的影响:系统性审查和元分析
Yu-Cheng Lin1, Tsu-Hsien Wang2, Yi-No Kang3
1Department of Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Foundation, New Taipei City, Taiwan.
The American journal of emergency medicine
|July 19, 2025
概括
特兰胺酸 (TXA) 有效地降低了儿科创伤患者的死亡率. 虽然通常是安全的,但需要进一步的研究来优化TXA的剂量和时间,以获得儿童的最佳结果.
科学领域:
- 儿科急救医学 儿科急救医学
- 创伤外科 手术 创伤外科
- 药理学 药理学是指药理学的学科.
背景情况:
- 在儿童中,创伤性出血带来了显著的死亡风险.
- 评估抗纤维解毒剂,如胺酸 (TXA),对于改善结果至关重要.
研究的目的:
- 系统地审查和元分析TXA在儿科创伤性出血中的疗效和安全性.
- 评估TXA对儿科创伤死亡率,发病率和不良事件的影响.
主要方法:
- 在主要数据库中对相关队列和随机对照试验进行全面的文献搜索.
- 纳入标准不包括其他抗出血剂或患有先前出血障碍的患者的研究.
- 统计分析利用随机效应模型来计算关键结果的几率比率.
主要成果:
- 分析了10项研究 (34144名儿童),包括1项RCT和9个回顾性队列.
- TXA显著降低了死亡率 (OR 0.58),特别是在1g的初始剂量下.
- 在ICU入院,手术干预或住院期间没有观察到显著差异;发作略有增加,但血栓栓塞事件没有增加.
结论:
- TXA在减少儿科创伤患者的死亡率方面显示出潜在的好处.
- 在这一群体中,TXA的整体安全性概况似乎是有利的.
- 需要进一步的研究来确定TXA在儿科创伤中的最佳剂量和时间.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
913
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
913
Disorders of Hemostasis
1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
Extrinsic and Intrinsic Pathways of Hemostasis
9.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.2K
Venous Thrombosis III: Interprofessional Care
23
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
23
Introduction to Hemostasis
8.9K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.9K
Venous Thrombosis IV: Nursing Management
24
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
24

